Pharmaceuticals, Biotechnology and Life Sciences
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma. SAN DIEGO, Calif.,…
Activity Report for Quarter Ended June 30, 2025 (Appendix 4C)NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO;…
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New…
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company…
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that…
PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and…
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July…
SOUTH SAN FRANCISCO, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation…
Increases total holdings to 1,427,178 HYPELAGUNA HILLS, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion…